chlorphenesin piperidinol hydrochloride

Chlorphenesin piperidinol hydrochloride is a small molecule analgesic and centrally acting muscle relaxant being developed by Beijing Shiqiao Biological Pharmaceutical in collaboration with the Institute of Materia Medica, Chinese Academy of Medical Sciences. As a derivative of chlorphenesin, it is designed to treat acute pain, specifically in the context of major orthopedic surgeries. The drug is currently in Phase II clinical development in China, where it is being evaluated for its efficacy in managing postoperative pain following total hip or knee arthroplasty. Its mechanism of action involves the depression of polysynaptic transmission within the spinal cord and subcortical areas of the brain, leading to muscle relaxation and a reduction in pain signaling.

Other names

chlorphenesin piperidinol hydrochloridechlorphenesin piperidinol HCl